-+ 0.00%
-+ 0.00%
-+ 0.00%

CONNECT BIOPHARMA - PLANS FDA MEETING FOR PHASE 3 ASTHMA IN DEC 2026 AND COPD IN Q1 2027

Reuters·11/16/2026 21:05:01

Please log in to view news